AJP - Renal Physiology, Vol 252, Issue 2 299-F303, Copyright © 1987 by American Physiological Society

ARTICLES

Renal effects of selective adenosine receptor agonists in anesthetized rats

P. C. Churchill and A. Bidani

Exogenous adenosine affects renal hemodynamics, renal tubular transport processes, and the secretion of renin. However, adenosine is not a selective agonist; it activates both A1 and A2 cell-surface receptors and it binds to an intracellular P-site that inhibits adenylate cyclase activity. Recent in vitro studies have suggested that activation of A1- and A2- adenosine receptors results in opposite effects on renin secretion. The purpose of these experiments was to examine the renal effects of A1- and A2-adenosine receptor agonists in vivo. 5'-N-ethylcarboxamide adenosine (NECA), 2-chloroadenosine (2-CLA), and N6-cyclohexyladenosine (CHA) were infused intravenously at rates that produced comparable decreases in systemic arterial blood pressure. All three of these adenosine analogues produced comparable decreases in para-aminohippurate (PAH) and inulin clearances and in Na and K excretion rates. CHA, an A1-selective agonist, markedly decreased plasma renin concentration (PRC), whereas NECA, an A2-selective agonist, markedly increased PRC; 2-CLA, a nonselective agonist, produced a smaller increase in PRC. Taken together, these results suggest that occupation of A1- and A2-receptors inhibits and stimulates renin secretion in vivo, independently of the effects of these adenosine receptor agonists on arterial blood pressure, renal hemodynamics, and tubular Na and K transport.

This article has been cited by other articles:

				V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF]

				F. Schweda, C. Wagner, B. K. Kramer, J. Schnermann, and A. Kurtz Preserved macula densa-dependent renin secretion in A1 adenosine receptor knockout mice Am J Physiol Renal Physiol, April 1, 2003; 284(4): F770 - F777. [Abstract] [Full Text] [PDF]

				T. Schiavello, V. Burke, N. Bogdanova, P. Jasik, S. Melsom, N. Boudville, K. Robertson, D. Angelicheva, B. Dworniczak, M. Lemmens, et al. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2323 - 2327. [Abstract] [Full Text] [PDF]

				E. W. Inscho P2 receptors in regulation of renal microvascular function Am J Physiol Renal Physiol, June 1, 2001; 280(6): F927 - F944. [Abstract] [Full Text] [PDF]

				H. T. Lee and C. W. Emala Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A1 and A3 receptors Am J Physiol Renal Physiol, March 1, 2000; 278(3): F380 - F387. [Abstract] [Full Text] [PDF]

				V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF]

				H. M. Siragy and J. Linden Sodium Intake Markedly Alters Renal Interstitial Fluid Adenosine Hypertension, March 1, 1996; 27(3): 404 - 407. [Abstract] [Full Text]